Molecular mechanisms of cancer treatments for solid tumours
Please be aware that this will be a virtual event. Details to be confirmed.
Description: This is a one-day course in which I describe the science behind a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: kinase inhibitors, monoclonal antibodies, PARP inhibitors, CDK inhibitors, immunotherapy with checkpoint inhibitors.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact: firstname.lastname@example.org
View the day’s programme